Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is one novel approach for canine cancer therapy. In this study we described for the first time the characterization and the use of new VACV strain LIVP6.1.1 as an oncolytic agent against canine cancer in a panel of four canine cance...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gentschev, Ivaylo, Patil, Sandeep S., Adelfinger, Marion, Weibel, Stephanie, Geissinger, Ulrike, Frentzen, Alexa, Chen, Nanhai G., Yu, Yong A., Zhang, Qian, Ogilvie, Gregory, Szalay, Aladar A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2013
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609626/
https://ncbi.nlm.nih.gov/pubmed/23093804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/bioe.22462
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky